ArticlePloS one2025
Mediating role of systemic inflammation in linking transferrin saturation to all-cause mortality in patients with coronary artery disease: Evidence from a large population-based study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Causal Association Between Transferrin Saturation and Periodontitis: A Mendelian Randomization Study.Oral health & preventive dentistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTransferrin saturation (TS) is associated with mortality across populations, but its nonlinear relationship with all-cause mortality in coronary artery disease (CAD) and the role of systemic inflammation remain unclear. This study explored the association between TS and mortality in CAD patients, focusing on systemic inflammation as a potential mediator.
methodsData from National Health and Nutrition Examination Survey (NHANES) 1999-2006 included 769 CAD patients (>18 years) with available TS and mortality records. Systemic inflammation markers, such as the systemic immune-inflammation index (SII) and systemic inflammation response index (SIRI), were analyzed. Kaplan-Meier curves, Cox proportional hazards models, and mediation analyses examined the interactions between TS, inflammation, and mortality.
resultsA U-shaped relationship between TS and all-cause mortality was observed, with an inflection point at 30.5%. TS levels ≤30.5% were inversely associated with mortality (HR = 0.98; 95% CI, 0.96-0.99; P < 0.0001), while levels >30.5% increased mortality risk (HR = 1.05; 95% CI, 1.02-1.08; P < 0.001). Systemic inflammation markers (SII/SIRI) were associated with and may partially mediate the relationship between low TS (≤30.5%) and mortality. (mediation proportions: 28.5% and 21.8%, respectively). No mediation effects were found for TS > 30.5%.
conclusionsTS demonstrates a U-shaped relationship with all-cause mortality in CAD patients. Systemic inflammation is linked to both TS and mortality outcomes, suggesting potential mechanistic interplay. Maintaining TS within 20-30% and addressing inflammation may reduce mortality risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.